SAMHD1 is a barrier to antimetabolite-based cancer...

Molecular & Cellular Oncology 2017 / 03 Vol. 4; Iss. 2

SAMHD1 is a barrier to antimetabolite-based cancer therapies

Rudd, Sean G., Schaller, Torsten, Herold, Nikolas
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Language:
english
Journal:
Molecular & Cellular Oncology
DOI:
10.1080/23723556.2017.1287554
Date:
March, 2017
File:
PDF, 1.76 MB
english, 2017
Conversion to is in progress
Conversion to is failed